Scarica l'app Stockscreener
236.88
0.36%
-0.89
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Quest Diagnostics Inc Borsa (DGX) Ultime notizie
Quest Diagnostics Incorporated (NYSE:DGX) Plans Quarterly Dividend of $0.86 - MarketBeat
Q2 2026 Quest Diagnostics Inc Earnings Call Transcript - GuruFocus
Quest Diagnostics Keeps Quarterly Dividend at $0.86 per Share, Payable Oct. 21, to Shareholders of Record Oct. 6 - marketscreener.com
Quest Diagnostics Sets Oct. 21 Date for Cash Dividend - Stock Titan
Diversified Management Inc. Lowers Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
IVY LANE CAPITAL MANAGEMENT, LLC's Quest Diagnostics Inc(DGX) Holding History - GuruFocus
Quest Diagnostics Incorporated $DGX Holdings Trimmed by Empowered Funds LLC - MarketBeat
Quest Diagnostics Inc (DGX) Stock News Today - TradingKey
Quest Diagnostics Inc (DGX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Quest Diagnostics Inc (DGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Is Quest Diagnostics (DGX) A Bargain Following Raised Guidance And Strong Quarterly Results? - Yahoo Finance
Quest Diagnostics (DGX) Stock May Be 32% Undervalued As Guidance Rises - Yahoo Finance
Arrowstreet Capital Limited Partnership Purchases New Shares in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Bought by Eastern Bank - MarketBeat
Royal Bank of Canada Has $38.91 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Raises 2026 Outlook as Testing Demand Accelerates - The Globe and Mail
Bank of America Corp DE Acquires 129,964 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Cetera Investment Advisers Acquires 8,362 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
California State Teachers Retirement System Sells 5,763 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Alpine Woods Capital Investors LLC Cuts Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Is DGX Stock Worth Buying After Its Strong 2026 Earnings Momentum? - Yahoo Finance
PR News | On the Move: Quest Diagnostics Names Chokshi IR ChiefThu., Jul. 30, 2026 - odwyerpr.com
Quest Diagnostics Incorporated $DGX Shares Sold by Lazard Asset Management LLC - MarketBeat
Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $248.86, Implies 6% Upside - TradingView
OMERS ADMINISTRATION Corp Buys 10,073 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Insider at DGX (NYSE: DGX) plans sale of 1,600 common shares - Stock Titan
JPMorgan Adjusts Price Target on Quest Diagnostics to $250 From $220, Maintains Neutral Rating - marketscreener.com
DGX|Quest Diagnostics Inc|Price:231.750|Chg%:+3.890 - TradingKey
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Quest Diagnostics Inc (DGX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Form 4 Quest Diagnostics orporated For: 28 July By Investing.com - Investing.com South Africa
Quest Diagnostics Inc (DGX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Quest Diagnostics Incorporated (DGX) Stock Forecasts - Yahoo Finance
Quest Diagnostics (NYSE: DGX) SVP adds shares via dividend reinvestment plan - Stock Titan
Quest Diagnostics (NYSE: DGX) SVP acquires 34.0000 shares via dividend reinvestment - Stock Titan
Rothschild & Co Redburn Adjusts Quest Diagnostics Price Target to $251 From $233, Maintains Buy Rating - Moomoo
Quest Diagnostics Incorporated (NYSE:DGX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Quest Diagnostics (DGX) Leads S&P 500 Healthcare Gainers with 8. - GuruFocus
Quest Diagnostics Incorporated (DGX) Stock forecasts - Yahoo Finance Singapore
Why Quest Diagnostics (DGX) Is Up 8.2% After Raising 2026 Guidance And Boosting Buybacks - Yahoo Finance
Quest Diagnostics stock trades steady as earnings and diagnostics demand shape investor focus - Ad-hoc-news.de
Quest Diagnostics Inc (DGX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Quest Diagnostics Inc (DGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Truist Financial Reaffirms Their Hold Rating on Quest Diagnostics (DGX) - The Globe and Mail
Quest Diagnostics Inc (DGX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Quest Diagnostics Is Maintained at Outperform by Mizuho - Moomoo
Quest Diagnostics Inc (DGX) Cash Flow - TradingKey
DGX|Quest Diagnostics Inc|Price:235.424|Chg%:+1.704 - TradingKey
DGX|Quest Diagnostics Inc|Price:227.860|Chg%:-0.050 - TradingKey
Quest Diagnostics Inc (DGX) Institutional Confidence - TradingKey
Quest Diagnostics (DGX) Stock Gets Fair Value Boost After Q2 Beat And Higher Guidance - Yahoo Finance
Quest Diagnostics Incorporated Revenue Breakdown – NYSE:DGX - TradingView
Quest Diagnostics Q2 2026 Earnings: Net Income, Revenues, and Financial Highlights from SEC 10-Q Filing - Minichart
QUEST DIAGNOSTICS INC : TRUIST SECURITIES RAISES TARGET PRICE TO $250 FROM $225 - Bitget
UBS Adjusts Price Target on Quest Diagnostics to $232 From $220, Maintains Neutral Rating - marketscreener.com
Baird Adjusts Quest Diagnostics Price Target to $255 From $236, Maintains Neutral Rating - marketscreener.com
Barclays Raises Quest Diagnostics Price Target to $250 From $230, Maintains Overweight Rating - marketscreener.com
Mizuho Securities Adjusts Quest Diagnostics Price Target to $260 From $235, Maintains Outperform Rating - marketscreener.com
Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $241.73, Implies 6% Upside - TradingView
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Deutsche Bank Adjusts Quest Diagnostics Price Target to $232 From $205, Maintains Hold Rating - marketscreener.com
Truist Raises Price Target on Quest Diagnostics to $250 From $225, Keeps Hold Rating - marketscreener.com
Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $240.93, Implies 6% Upside - TradingView
Quest Diagnostics Upgrades EPS Outlook For 2026 After Outperforming Q2 Results (NYSE:DGX) - Seeking Alpha
Morgan Stanley Adjusts PT on Quest Diagnostics to $260 From $226, Maintains Overweight Rating - marketscreener.com
Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $239.27, Implies 5% Upside - TradingView
Quest Diagnostics stock trades steady as investors weigh recent earnings and diagnostics demand - Ad-hoc-news.de
Trending Industry Today: Quest Diagnostics Leads Gains In CRO Stocks - Moomoo
0.80%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):